Titlebook: Regulatory Aspects of Gene Therapy and Cell Therapy Products; A Global Perspective Maria Cristina Galli Book 2023Latest edition The Editor(

審美家

書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products影響因子(影響力)




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products影響因子(影響力)學科排名




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products網(wǎng)絡(luò)公開度




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products網(wǎng)絡(luò)公開度學科排名




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products被引頻次




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products被引頻次學科排名




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products年度引用




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products年度引用學科排名




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products讀者反饋




書目名稱Regulatory Aspects of Gene Therapy and Cell Therapy Products讀者反饋學科排名

inscribe

Ordeal

Regulatory Oversight of Cell, Tissue, and Gene Therapy Products in Singapore,innovative CTGTP with a least burdensome regulatory framework while ensuring reasonable safeguards on the safety, quality, and efficacy of the products. This chapter describes the regulatory oversight of CTGTP in Singapore.

Indigence

Regulatory Aspects of Cell and Gene Therapy Products: The Japanese Perspective,f a new scheme for obtaining conditional and time-limited approval for CGT products. Overall, research and development on CGT products, especially gene therapy products, is progressing. New legislative frameworks have been designed to promote the timely development of new technologies and safe and effective CGT products for Japanese patients.

壓碎

Regulatory Oversight of Cell and Gene Therapy Products in Malaysia,h-risk CGTP is similar to other biological products. This chapter describes the chronology of the CGTP framework, classification of CGTP, how CGTPs fit into the current registration pathways and registration procedure, dossier requirements, and what is the current status and future direction of CGTP in Malaysia.

遵循的規(guī)范

Regulatory Frameworks for Advanced Therapy Medicinal Products in Thailand,products are applied to ATMP in clinical trials and marketing authorization applications. At the same time, the specific guidelines for ATMPs are under development. This chapter provides an overview of the Thai FDA regulatory oversight of ATMPs, which covers investigational ATMPs, GMP certification, and marketing authorization.

addition

賭博

Book 2023Latest editionrica, Europe and Asia and by international bodies in the effort of international harmonization..This book represents an update of the first edition, as it covers regulatory novelties and accumulated experience in the regions already addressed. In addition, this new edition offers a wider internation

缺陷

United States Food and Drug Administration Regulation of Human Cells, Tissues, and Gene Therapies,g others, throughout the entire product lifecycle. This chapter provides an overview of the science- and data-driven approach to US FDA regulatory oversight of cell and gene?therapy (CGT) products to ensure their safety and efficacy.

Anhydrous

Marketing Regulatory Oversight of Advanced Therapy Medicinal Products in Europe,sue-engineered products. Under this framework, ATMP are authorised by the centralised procedure, coordinated by the European Medicines Agency (EMA), whereas clinical trial authorisations remain at the remit of each National Competent Authority. The Committee for Advanced Therapies is responsible for